ABTAbbott Laboratories

$105.58

$82.5652 weeks$134.49

Is the price fair?

Abbott Laboratories trades at 29.5× earnings against 30.9× for the median Medical Devices name, cheaper than its own group.

29.5

Trailing P/E · Medical Devices median 30.9 · cheaper than the typical name in its group

Price / sales: 3.95
Price / sales · as of 2026-Q1
Free cash flow yield: 4.8%
Free cash flow yield · Medical Devices median 3.9%
Growth the price implies: +6.2%
Growth the price implies · The price pays for +6.2% free cash flow growth a year for a decade; the business has delivered +2.6% a year over the last three.

Details›

What the market has paid for these earnings: 37 quarters of its own multiple × $3.58 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$98.76
Its own P/E history, median	$118.30
Its own P/E history, upper quartile	$154.73
52-week range	$82.56 – $134.49
Today	$105.58

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

The closest names by size in the same industry